2024 Hands-On Training for Upstream Process in Cell-Based Vaccine Manufacturing
Deadline for applications: August 23, 2024, 18:00 (KST)
The 2024 Hands-On Training for Upstream Process in Cell-Based Vaccine Manufacturing is a 5–6-week program (including a pre-online training course) at the International Vaccine Institute (IVI) and the Korea Biopharmaceutical CMO Centre (K-Bio CMO), targeting 20 individuals and focusing on the upstream process in cell-based vaccine manufacturing.
The purpose of the training is to enhance the technical knowledge and capabilities of vaccine and biopharmaceutical manufacturers from LMICs in the processes of vaccine research, development, and manufacturing. The focus is on providing extensive hands-on training in industrial facilities, enabling participants to gain practical experience and a deeper understanding of the intricacies involved in vaccine production.
Course Information (In-person training, Republic of Korea)
- Course Content: Didactic training on overall vaccine development process and hands-on training on upstream process development including cell culture, virus infection, harvest & clarification.
- Target Trainees: 20 Trainees from Low- and Middle-Income Countries (LMICs).
- Trainee Qualification: Technician, engineer, scientist, or manager in biomanufacturing or a related field, with up to 6 years of experience.
APPLICANTS ARE ALLOWED TO APPLY TO ONLY ONE OF THE FOLLOWING HANDS-ON TRAINING PROGRAMS:
- 2024 Hands-on Training for Upstream Process in Cell-Based Vaccine Manufacturing
- 2024 Hands-on Training for mRNA Vaccine Manufacturing